Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Oct 13, 2026

PVLA — Palvella Therapeutics, Inc. Dilution Risk Tracker

Track PVLA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PVLA — Get alerts when the score changes →

As of October 13, 2026, Palvella Therapeutics, Inc. (PVLA) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Palvella Therapeutics, Inc. has a market capitalization of $1.94B, 14.41M shares outstanding, 185 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $200.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $200M remaining capacity
🔔 Track PVLA — Get forecast alerts →

Market Data

Market Cap$1.94B
Shares Outstanding14.41M
Float9.58M
Cash$250.58M
Debt$20.38M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore41/100DilutionWatch score record
Shares Outstanding14.41MVerified float table or market cache
Public Float9.58MVerified float table or market cache
Market Cap$1.94BMarket data cache
Cash Runway84.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$200.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 3, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 48.7% shares (2026Q1 vs prior)
185 institutional holders · 15.08M shares
#1 SUVRETTA CAPITAL MANAGEMENT, LLC 1.15M shares
#2 First Light Asset Management, LLC 980.8K shares
#3 BVF INC/IL 961.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.52M
Days to Cover10.7
% of Float26.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-31
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-15
3 FORM3 2026-04-15
8-K 8K EVENT 2026-04-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PVLA Dilution Snapshot

Palvella Therapeutics, Inc. (PVLA) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PVLA's DilutionScore is currently 41/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 37/100 (Medium risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202641/100MEDIUM60 days
Jul 16 – Aug 13, 202637/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PVLA shares outstanding have increased 21.2% from 11.84M (Mar 2026) to 14.34M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 202614.34M9.58M▼ 4.99%
May 16, 202614.34M10.08M▲ 0.09%
May 12, 202614.34M10.07M▲ 8.43%
May 09, 202614.34M9.29M▲ 0.20%
Apr 07, 202614.31M9.27M▲ 3.68%
Apr 01, 202614.31M8.94M▲ 20.93%
Mar 11, 202613.99M7.39M▼ 0.02%
Mar 05, 202611.84M7.40M▼ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PVLA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PVLA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PVLA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PVLA
PVLA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.